youtube_live
Q2 2026 earnings • released • EPS beat +110,90% • Revenue miss -0,21%
See resultschevron_right
A1ZN34:BVMF
Astrazeneca Plc Bdr
148,07 R$
arrow_upward
+0,59%(+0,87) 1D
29 հլս, 16:56:00 GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1ZN34...
Open
148,00 R$
High
149,01 R$
Low
148,00 R$
Mkt. cap
267,94 մլրդ
Avg. vol.
185,00
Volume
75,00
52-wk high
190,40 R$
52-wk low
130,02 R$
Shares outstanding
1,55 մլրդ
No. of employees
96 հզր
Open
148,00 R$
High
149,01 R$
Low
148,00 R$
Mkt. cap
267,94 մլրդ
Avg. vol.
185,00
Volume
75,00
52-wk high
190,40 R$
52-wk low
130,02 R$
Shares outstanding
1,55 մլրդ
No. of employees
96 հզր
News stories
From sources across the web
Quiver Quantitative
·
3 ժամ առաջ
Fund Update: 42,335 ASTRAZENECA (AZN) shares added to STEPHENS INC |AR| portfolio
BioPharma Dive
·
5 ժամ առաջ
Earnings roundup: Biogen’s ‘resiliency,’ AstraZeneca’s growth pitch and GSK’s oncology push
JournalArta
·
18 ժամ առաջ
AstraZeneca Momentum Weakens: Stock Gains 2.13% (Juli 29, 2026)
Law360
·
21 ժամ առաջ
This Week's Healthcare Earnings: Tenet, CHS, AstraZeneca
Profile
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, England; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
About Astrazeneca Plc Bdr
CEOPascal Soriot
Employees96,1 հզր
Founded06 ապր, 1999 թ.
HeadquartersՔեմբրիջ, Cambridgeshire, Միացյալ Թագավորություն
Sector-
Websiteastrazeneca.com
AI content may include mistakes. Learn more